CIBRA Capital Increases Stake in Amicus Therapeutics (FOLD) by Over 1 Million Shares
CIBRA Capital significantly increased its stake in Amicus Therapeutics (FOLD) by purchasing 1,476,861 shares, valued at approximately $21.17 million. This move increased the position's value to $24.40 million, representing 11.78% of the fund’s AUM, making it the top holding. The transaction reflects a 10.2% change in the fund's assets under management.
Tickers: $FOLD
Topics: Amicus Therapeutics portfolio changes SEC filing stock trading